Fredag 3 Juli | 18:06:37 Europe / Stockholm
Est. tid*
2026-10-23 07:30 Kvartalsrapport 2026-Q3
2026-08-26 07:30 Kvartalsrapport 2026-Q2
2026-04-29 - Kvartalsrapport 2026-Q1
2026-04-14 - X-dag ordinarie utdelning SLEEP 0.53 SEK
2026-04-13 - Årsstämma
2026-02-04 - Bokslutskommuniké 2025
2025-10-28 - Extra Bolagsstämma 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-08-22 - Kvartalsrapport 2025-Q2
2025-04-25 - Kvartalsrapport 2025-Q1
2025-04-09 - X-dag bonusutdelning SLEEP 1.15
2025-04-09 - X-dag ordinarie utdelning SLEEP 1.85 SEK
2025-04-08 - Årsstämma
2025-02-04 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-26 - Kvartalsrapport 2024-Q2
2024-05-03 - Kvartalsrapport 2024-Q1
2024-04-12 - X-dag ordinarie utdelning SLEEP 1.30 SEK
2024-04-12 - X-dag bonusutdelning SLEEP 1
2024-04-11 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2023-11-23 - Extra Bolagsstämma 2023
2023-10-25 - Kvartalsrapport 2023-Q3
2023-07-27 - Kvartalsrapport 2023-Q2
2023-05-09 - X-dag bonusutdelning SLEEP 6
2023-05-09 - X-dag ordinarie utdelning SLEEP 1.00 SEK
2023-05-08 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-02-10 - Bokslutskommuniké 2022
2022-10-28 - Kvartalsrapport 2022-Q3
2022-07-29 - Kvartalsrapport 2022-Q2
2022-05-11 - X-dag ordinarie utdelning SLEEP 0.00 SEK
2022-05-10 - Årsstämma
2022-04-27 - Kvartalsrapport 2022-Q1
2022-02-15 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-13 - Kvartalsrapport 2021-Q2
LandSverige
ListaSmall Cap Stockholm
SektorInformationsteknik
IndustriProgramvara
Sleep Cycle är ett sömnteknikbolag som utvecklar digitala lösningar för analys och förståelse av sömn inom digital hälsa och medicinteknik. Bolaget grundades 2009 och erbjuder en mobilapplikation som hjälper användare att förstå sina sömnmönster och utveckla bättre sömnvanor genom analys av sömndata. Sleep Cycle erbjuder även tekniska lösningar, inklusive SDK och sömndata, till företag som integrerar sömnfunktioner i sina tjänster. Huvudkontoret ligger i Göteborg.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Sleep Cycle signs commercial SDK licensing agreement with Ultrahuman following successful pilot

2026-07-03 07:30:00

Sleep Cycle, the leading AI-powered sleep technology company, today announced that it has signed a commercial licensing agreement with Ultrahuman, a global health and wearable technology company. The agreement governs Ultrahuman’s continued use of Sleep Cycle’s proprietary Sleep SDK and follows a successful pilot collaboration initiated in November 2025.

The pilot was established to evaluate how Sleep Cycle’s audio-based sleep and respiratory intelligence could strengthen Ultrahuman’s health platform. The Respiratory Health PowerPlug combined Sleep Cycle’s sleep and respiratory intelligence with biometric signals from Ultrahuman Ring to reveal patterns, trends, and changes in snoring, coughing and respiratory disturbances.

During the pilot period, Ultrahuman's Respiratory Health PowerPlug became one of Ultrahuman's best-performing PowerPlugs. Following these results, the parties have agreed to expand the collaboration under a commercial SDK licensing agreement.

Under the agreement, Ultrahuman will continue to integrate Sleep Cycle’s technology into its platform under the “Powered by Sleep Cycle” framework. Sleep Cycle’s revenue is linked to adoption and growth within the Ultrahuman ecosystem, aligning the interests of both parties as the collaboration scales.

“The pilot demonstrated that our technology creates value not only in our own application, but also within partner ecosystems. Moving from pilot to commercial agreement with Ultrahuman is an important milestone for our Powered by Sleep Cycle strategy and further validates the demand for our technology in the global health and wearables market,” says Erik Jivmark, CEO of Sleep Cycle.

“Breathing disruptions that fragment sleep are linked to long-term cardiovascular risk, yet they remain largely invisible to most people. The success of the Respiratory Health PowerPlug, which is powered by Sleep Cycle, demonstrated the value of making these signals accessible and actionable, which supports long-term health outcomes, while complementing the broader health ecosystem we're building. We're excited to deepen this partnership and accelerate the future of preventive health," says Mohit Kumar, Founder and CEO of Ultrahuman.

The agreement represents an important milestone in Sleep Cycle’s Powered by Sleep Cycle licensing strategy and further demonstrates the applicability of the company’s technology beyond its own consumer application.

For more information, please contact: